Pharmacology and physiology of gastrointestinal enteroendocrine cells
Gastrointestinal (GI) polypeptides are secreted from enteroendocrine cells (EECs). Recent technical advances and the identification of endogenous and synthetic ligands have enabled exploration of the pharmacology and physiology of EECs. Enteroendocrine signaling pathways stimulating hormone secretio...
Gespeichert in:
Veröffentlicht in: | Pharmacology research & perspectives 2015-08, Vol.3 (4), p.e00155-n/a |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | n/a |
---|---|
container_issue | 4 |
container_start_page | e00155 |
container_title | Pharmacology research & perspectives |
container_volume | 3 |
creator | Mace, O. J. Tehan, B. Marshall, F. |
description | Gastrointestinal (GI) polypeptides are secreted from enteroendocrine cells (EECs). Recent technical advances and the identification of endogenous and synthetic ligands have enabled exploration of the pharmacology and physiology of EECs. Enteroendocrine signaling pathways stimulating hormone secretion involve multiple nutrient transporters and G protein‐coupled receptors (GPCRs), which are activated simultaneously under prevailing nutrient conditions in the intestine following a meal. The majority of studies investigate hormone secretion from EECs in response to single ligands and although the mechanisms behind how individual signaling pathways generate a hormonal output have been well characterized, our understanding of how these signaling pathways converge to generate a single hormone secretory response is still in its infancy. However, a picture is beginning to emerge of how nutrients and full, partial, or allosteric GPCR ligands differentially regulate the enteroendocrine system and its interaction with the enteric and central nervous system. So far, activation of multiple pathways underlies drug discovery efforts to harness the therapeutic potential of the enteroendocrine system to mimic the phenotypic changes observed in patients who have undergone Roux‐en‐Y gastric surgery. Typically obese patients exhibit ~30% weight loss and greater than 80% of obese diabetics show remission of diabetes. Targeting combinations of enteroendocrine signaling pathways that work synergistically may manifest with significant, differentiated EEC secretory efficacy. Furthermore, allosteric modulators with their increased selectivity, self‐limiting activity, and structural novelty may translate into more promising enteroendocrine drugs. Together with the potential to bias enteroendocrine GPCR signaling and/or to activate multiple divergent signaling pathways highlights the considerable range of therapeutic possibilities available. Here, we review the pharmacology and physiology of the EEC system. |
doi_str_mv | 10.1002/prp2.155 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4506687</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2290060199</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5045-7ec5810a1542ce75285539802763271dfdaa6aa205bcb8cc93f7f83d81c16da43</originalsourceid><addsrcrecordid>eNp1kV1LwzAUhoMobsyBv0AK3njTeZI2SXsjiMwPGDhEr0OWpltG29RkVfbvzdicU_AqJ-Th4T15ETrHMMIA5Lp1LRlhSo9QnwAlMebAjw_mHhp6vwQAjFPACTlFPcIIThjhfTSeLqSrpbKVna8j2RRRu1h7s73aMppLv3LWNCvtV6aRVaTD6KxuCqucaXSkdFX5M3RSysrr4e4coLf78evdYzx5fni6u53EikJKY64VzTBITFOiNKckozTJMyCcJYTjoiykZFKG5DM1y5TKk5KXWVJkWGFWyDQZoJutt-1mtS5UCONkJVpnaunWwkojfr80ZiHm9kOkFBjLeBBc7QTOvndhJ1Ebv1lBNtp2XmCW52mepIwE9PIPurSdC1_gBSE5AAOc5z9C5az3Tpf7MBjEph6xqUeEegJ6cRh-D36XEYB4C3yaSq__FYnpy5RshF_4zJm2</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2290060199</pqid></control><display><type>article</type><title>Pharmacology and physiology of gastrointestinal enteroendocrine cells</title><source>Wiley Online Library Open Access</source><source>DOAJ Directory of Open Access Journals</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Mace, O. J. ; Tehan, B. ; Marshall, F.</creator><creatorcontrib>Mace, O. J. ; Tehan, B. ; Marshall, F.</creatorcontrib><description>Gastrointestinal (GI) polypeptides are secreted from enteroendocrine cells (EECs). Recent technical advances and the identification of endogenous and synthetic ligands have enabled exploration of the pharmacology and physiology of EECs. Enteroendocrine signaling pathways stimulating hormone secretion involve multiple nutrient transporters and G protein‐coupled receptors (GPCRs), which are activated simultaneously under prevailing nutrient conditions in the intestine following a meal. The majority of studies investigate hormone secretion from EECs in response to single ligands and although the mechanisms behind how individual signaling pathways generate a hormonal output have been well characterized, our understanding of how these signaling pathways converge to generate a single hormone secretory response is still in its infancy. However, a picture is beginning to emerge of how nutrients and full, partial, or allosteric GPCR ligands differentially regulate the enteroendocrine system and its interaction with the enteric and central nervous system. So far, activation of multiple pathways underlies drug discovery efforts to harness the therapeutic potential of the enteroendocrine system to mimic the phenotypic changes observed in patients who have undergone Roux‐en‐Y gastric surgery. Typically obese patients exhibit ~30% weight loss and greater than 80% of obese diabetics show remission of diabetes. Targeting combinations of enteroendocrine signaling pathways that work synergistically may manifest with significant, differentiated EEC secretory efficacy. Furthermore, allosteric modulators with their increased selectivity, self‐limiting activity, and structural novelty may translate into more promising enteroendocrine drugs. Together with the potential to bias enteroendocrine GPCR signaling and/or to activate multiple divergent signaling pathways highlights the considerable range of therapeutic possibilities available. Here, we review the pharmacology and physiology of the EEC system.</description><identifier>ISSN: 2052-1707</identifier><identifier>EISSN: 2052-1707</identifier><identifier>DOI: 10.1002/prp2.155</identifier><identifier>PMID: 26213627</identifier><language>eng</language><publisher>United States: John Wiley & Sons, Inc</publisher><subject>Appetite ; Chemosensing ; diabetes ; Endocrine system ; enteroendocrine ; Enzymes ; Fatty acids ; Food ; GLP‐1 ; GPCR ; Hormones ; intestine ; Invited Reviews ; Kinases ; Metabolism ; Motility ; Nervous system ; Pancreas ; Peptides ; Pharmacology ; Physiology ; Proteins ; Small intestine ; Smooth muscle ; Stomach</subject><ispartof>Pharmacology research & perspectives, 2015-08, Vol.3 (4), p.e00155-n/a</ispartof><rights>2015 The Heptares Therapeutics. published by John Wiley & Sons Ltd, British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics.</rights><rights>2015. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2015 The Heptares Therapeutics. published by John Wiley & Sons Ltd, British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics. 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5045-7ec5810a1542ce75285539802763271dfdaa6aa205bcb8cc93f7f83d81c16da43</citedby><cites>FETCH-LOGICAL-c5045-7ec5810a1542ce75285539802763271dfdaa6aa205bcb8cc93f7f83d81c16da43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506687/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506687/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,1411,11541,27901,27902,45550,45551,46027,46451,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26213627$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mace, O. J.</creatorcontrib><creatorcontrib>Tehan, B.</creatorcontrib><creatorcontrib>Marshall, F.</creatorcontrib><title>Pharmacology and physiology of gastrointestinal enteroendocrine cells</title><title>Pharmacology research & perspectives</title><addtitle>Pharmacol Res Perspect</addtitle><description>Gastrointestinal (GI) polypeptides are secreted from enteroendocrine cells (EECs). Recent technical advances and the identification of endogenous and synthetic ligands have enabled exploration of the pharmacology and physiology of EECs. Enteroendocrine signaling pathways stimulating hormone secretion involve multiple nutrient transporters and G protein‐coupled receptors (GPCRs), which are activated simultaneously under prevailing nutrient conditions in the intestine following a meal. The majority of studies investigate hormone secretion from EECs in response to single ligands and although the mechanisms behind how individual signaling pathways generate a hormonal output have been well characterized, our understanding of how these signaling pathways converge to generate a single hormone secretory response is still in its infancy. However, a picture is beginning to emerge of how nutrients and full, partial, or allosteric GPCR ligands differentially regulate the enteroendocrine system and its interaction with the enteric and central nervous system. So far, activation of multiple pathways underlies drug discovery efforts to harness the therapeutic potential of the enteroendocrine system to mimic the phenotypic changes observed in patients who have undergone Roux‐en‐Y gastric surgery. Typically obese patients exhibit ~30% weight loss and greater than 80% of obese diabetics show remission of diabetes. Targeting combinations of enteroendocrine signaling pathways that work synergistically may manifest with significant, differentiated EEC secretory efficacy. Furthermore, allosteric modulators with their increased selectivity, self‐limiting activity, and structural novelty may translate into more promising enteroendocrine drugs. Together with the potential to bias enteroendocrine GPCR signaling and/or to activate multiple divergent signaling pathways highlights the considerable range of therapeutic possibilities available. Here, we review the pharmacology and physiology of the EEC system.</description><subject>Appetite</subject><subject>Chemosensing</subject><subject>diabetes</subject><subject>Endocrine system</subject><subject>enteroendocrine</subject><subject>Enzymes</subject><subject>Fatty acids</subject><subject>Food</subject><subject>GLP‐1</subject><subject>GPCR</subject><subject>Hormones</subject><subject>intestine</subject><subject>Invited Reviews</subject><subject>Kinases</subject><subject>Metabolism</subject><subject>Motility</subject><subject>Nervous system</subject><subject>Pancreas</subject><subject>Peptides</subject><subject>Pharmacology</subject><subject>Physiology</subject><subject>Proteins</subject><subject>Small intestine</subject><subject>Smooth muscle</subject><subject>Stomach</subject><issn>2052-1707</issn><issn>2052-1707</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kV1LwzAUhoMobsyBv0AK3njTeZI2SXsjiMwPGDhEr0OWpltG29RkVfbvzdicU_AqJ-Th4T15ETrHMMIA5Lp1LRlhSo9QnwAlMebAjw_mHhp6vwQAjFPACTlFPcIIThjhfTSeLqSrpbKVna8j2RRRu1h7s73aMppLv3LWNCvtV6aRVaTD6KxuCqucaXSkdFX5M3RSysrr4e4coLf78evdYzx5fni6u53EikJKY64VzTBITFOiNKckozTJMyCcJYTjoiykZFKG5DM1y5TKk5KXWVJkWGFWyDQZoJutt-1mtS5UCONkJVpnaunWwkojfr80ZiHm9kOkFBjLeBBc7QTOvndhJ1Ebv1lBNtp2XmCW52mepIwE9PIPurSdC1_gBSE5AAOc5z9C5az3Tpf7MBjEph6xqUeEegJ6cRh-D36XEYB4C3yaSq__FYnpy5RshF_4zJm2</recordid><startdate>201508</startdate><enddate>201508</enddate><creator>Mace, O. J.</creator><creator>Tehan, B.</creator><creator>Marshall, F.</creator><general>John Wiley & Sons, Inc</general><general>John Wiley & Sons, Ltd</general><scope>24P</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201508</creationdate><title>Pharmacology and physiology of gastrointestinal enteroendocrine cells</title><author>Mace, O. J. ; Tehan, B. ; Marshall, F.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5045-7ec5810a1542ce75285539802763271dfdaa6aa205bcb8cc93f7f83d81c16da43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Appetite</topic><topic>Chemosensing</topic><topic>diabetes</topic><topic>Endocrine system</topic><topic>enteroendocrine</topic><topic>Enzymes</topic><topic>Fatty acids</topic><topic>Food</topic><topic>GLP‐1</topic><topic>GPCR</topic><topic>Hormones</topic><topic>intestine</topic><topic>Invited Reviews</topic><topic>Kinases</topic><topic>Metabolism</topic><topic>Motility</topic><topic>Nervous system</topic><topic>Pancreas</topic><topic>Peptides</topic><topic>Pharmacology</topic><topic>Physiology</topic><topic>Proteins</topic><topic>Small intestine</topic><topic>Smooth muscle</topic><topic>Stomach</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mace, O. J.</creatorcontrib><creatorcontrib>Tehan, B.</creatorcontrib><creatorcontrib>Marshall, F.</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Pharmacology research & perspectives</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mace, O. J.</au><au>Tehan, B.</au><au>Marshall, F.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pharmacology and physiology of gastrointestinal enteroendocrine cells</atitle><jtitle>Pharmacology research & perspectives</jtitle><addtitle>Pharmacol Res Perspect</addtitle><date>2015-08</date><risdate>2015</risdate><volume>3</volume><issue>4</issue><spage>e00155</spage><epage>n/a</epage><pages>e00155-n/a</pages><issn>2052-1707</issn><eissn>2052-1707</eissn><abstract>Gastrointestinal (GI) polypeptides are secreted from enteroendocrine cells (EECs). Recent technical advances and the identification of endogenous and synthetic ligands have enabled exploration of the pharmacology and physiology of EECs. Enteroendocrine signaling pathways stimulating hormone secretion involve multiple nutrient transporters and G protein‐coupled receptors (GPCRs), which are activated simultaneously under prevailing nutrient conditions in the intestine following a meal. The majority of studies investigate hormone secretion from EECs in response to single ligands and although the mechanisms behind how individual signaling pathways generate a hormonal output have been well characterized, our understanding of how these signaling pathways converge to generate a single hormone secretory response is still in its infancy. However, a picture is beginning to emerge of how nutrients and full, partial, or allosteric GPCR ligands differentially regulate the enteroendocrine system and its interaction with the enteric and central nervous system. So far, activation of multiple pathways underlies drug discovery efforts to harness the therapeutic potential of the enteroendocrine system to mimic the phenotypic changes observed in patients who have undergone Roux‐en‐Y gastric surgery. Typically obese patients exhibit ~30% weight loss and greater than 80% of obese diabetics show remission of diabetes. Targeting combinations of enteroendocrine signaling pathways that work synergistically may manifest with significant, differentiated EEC secretory efficacy. Furthermore, allosteric modulators with their increased selectivity, self‐limiting activity, and structural novelty may translate into more promising enteroendocrine drugs. Together with the potential to bias enteroendocrine GPCR signaling and/or to activate multiple divergent signaling pathways highlights the considerable range of therapeutic possibilities available. Here, we review the pharmacology and physiology of the EEC system.</abstract><cop>United States</cop><pub>John Wiley & Sons, Inc</pub><pmid>26213627</pmid><doi>10.1002/prp2.155</doi><tpages>26</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2052-1707 |
ispartof | Pharmacology research & perspectives, 2015-08, Vol.3 (4), p.e00155-n/a |
issn | 2052-1707 2052-1707 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4506687 |
source | Wiley Online Library Open Access; DOAJ Directory of Open Access Journals; Wiley Online Library Journals Frontfile Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central |
subjects | Appetite Chemosensing diabetes Endocrine system enteroendocrine Enzymes Fatty acids Food GLP‐1 GPCR Hormones intestine Invited Reviews Kinases Metabolism Motility Nervous system Pancreas Peptides Pharmacology Physiology Proteins Small intestine Smooth muscle Stomach |
title | Pharmacology and physiology of gastrointestinal enteroendocrine cells |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T12%3A50%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pharmacology%20and%20physiology%20of%20gastrointestinal%20enteroendocrine%20cells&rft.jtitle=Pharmacology%20research%20&%20perspectives&rft.au=Mace,%20O.%20J.&rft.date=2015-08&rft.volume=3&rft.issue=4&rft.spage=e00155&rft.epage=n/a&rft.pages=e00155-n/a&rft.issn=2052-1707&rft.eissn=2052-1707&rft_id=info:doi/10.1002/prp2.155&rft_dat=%3Cproquest_pubme%3E2290060199%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2290060199&rft_id=info:pmid/26213627&rfr_iscdi=true |